Phase II Trial of 5-FU, Leucovorin, Gemcitabine, and Cisplatin for Adenocarcinomas of the Urothelial Tract and Urachal Remnant
The goal of this clinical research study is to learn if treatment with a combination of 4 chemotherapy drugs can help to shrink or slow the growth of adenocarcinoma. The drugs used in the combination chemotherapy are: 5-fluorouracil (5FU), leucovorin, gemcitabine, and cisplatin.
Treatment Location: N/A
To estimate the response rate and overall survival of patients with metastatic or unresectable adenocarcinomas of the urothelial tract or urachal remnant who are treated with combination chemotherapy consisting of 5-FU, leucovorin, gemcitabine and cisplatin.
IRB Review and Approval Date: APR 16,2003
Recruitment Status: Closed
Projected Accrual: N/A
Information and next steps
Genitourinary Medical Oncology
For general questions about clinical trials: